GlassScriptPhysician profile
David M Kaufman
NPI 1124103817
$3,782.55
in general payments reported to CMS, 2019-2025
17 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.83 · 2020: $2,220 · 2021: $548 · 2022: $115 · 2023: $444 · 2024: $153 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.04 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $2,000.00 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $452.83 | 2020-2025 | Austedo Xr, Austedo Xr |
| Abbott Laboratories | $326.87 | 2023-2025 | Eterna, Proclaim |
| Neurocrine Biosciences, INC. | $212.13 | 2021-2022 | |
| Fisher & Paykel Healthcare INC | $185.38 | 2021 | |
| Kyowa Kirin, INC. | $124.11 | 2021 | |
| Livanova USA, INC. | $80.57 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Azurity Pharmaceuticals, INC. | $60.99 | 2024-2025 | Zonisade |
| Abbvie INC. | $55.96 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $53.22 | 2025 | |
| Emd Serono, INC. | $51.83 | 2019 | |
| Boston Scientific Corporation | $43.14 | 2024 | Vercise |
| Evofem Biosciences, INC. | $37.24 | 2021 | |
| Allergan, INC. | $28.73 | 2020 | |
| Ucb, INC. | $25.55 | 2024 | Fintepla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $22.35 | 2020 | |
| Avion Pharmaceuticals | $21.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.